41 results
Page 2 of 3
S-3ASR
hk0ge 6fq
18 May 21
Automatic shelf registration
6:01am
8-K
EX-99.1
b24cswef rz9qf
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm
8-K
tbvnzkt03sdk6g306
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm
8-K
EX-99.1
4gq5emoe1at
16 Mar 21
Akero Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
8:10am
8-K
EX-99.1
gqs3nedofwyywi
12 Aug 20
Akero Therapeutics Reports SECOND Quarter 2020 Financial Results
4:25pm
424B4
11btqvfb jhp
8 Jul 20
Prospectus supplement with pricing info
8:30pm
S-3
ehu0amhl
1 Jul 20
Shelf registration
4:08pm
8-K
yke1bpvf8t 1u
30 Jun 20
Akero Announces Strongly Positive Histological Data
4:16pm
8-K
EX-99.1
rsbvpzvu1y7z0rnz
30 Jun 20
Akero Announces Strongly Positive Histological Data
4:16pm
DRS
zs0z7
15 May 20
Draft registration statement
12:00am
8-K
EX-99.1
ntgm4
13 May 20
Akero Therapeutics Reports first Quarter 2020 Financial Results
4:17pm
8-K
EX-99.1
bty7m2rslkzvo5rx
31 Mar 20
Regulation FD Disclosure
8:25am